Building negative incentives into value-based insurance design programs to discourage use of low-value care will involve a number of challenges.
Dan Greenberg, PhD
Advertisement
Articles by Dan Greenberg, PhD
A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence.
Advertisement
Latest Updated Articles
- Do Drug Formulary Policies Reflect Evidence of Value?
January 1st 2006
- Low-Value Services in Value-Based Insurance Design
April 7th 2010
- Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?
September 7th 2009
Advertisement
Advertisement
Trending on AJMC
1
Patient Portal Messages Outpace Office Visits
2
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
3
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
4
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
5